AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...

The Food and Drug Administration and Department of Health and Human Services announced moves Tuesday to phase out “all petroleum-based synthetic dyes” from the food supply in the United States ...

An even newer introduction, especially popular in Europe, is the 3-phase rectified power supply, which inherited many of the reliability benefits of its single-phase predecessor. Not much has been ...

Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare In this global phase III trial, 571 patients with newly diagnosed LA-PAC were randomly assigned to receive ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and ...

Galmed reported results from the Open-Label part of its Phase 3 NASH study, which demonstrated that treatment with Aramchol 300mg BID resulted in a high rate of subjects with histological fibrosis ...

Strike will instead move to develop a peaking power plant to supply the northern end of the SWIS grid. A Western Australian gas company has shelved its plans to build a $3 billion fertiliser plant ...

Rosa DeLauro, the top Democrat on the House Appropriations Committee, said in a statement that the plan is a “power grab for the White House and further allows unchecked billionaire Elon Musk ...

MADRID, May 6 (Reuters) - Nuclear power is needed to stabilise Spain's electrical system and the country should rethink its planned phase-out following last week's unprecedented blackout ...

Months after securing the full rights to anti-CD19 antibody Monjuvi (tafasitamab) from partner MorphoSys, Incyte has the data to potentially back a label expansion ... in a phase 3 study in ...

"In the open-label extension (OLE) from the Phase 2 MUIR and SHASTA-2 studies, extended treatment with 25 mg of plozasiran in patients with moderate to severely elevated triglycerides produced ...